Related references
Note: Only part of the references are listed.A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy
J. A. Lawrence et al.
JOURNAL OF CANCER SURVIVORSHIP (2016)
Doxorubicin and cyclophosphamide lead to long-lasting impairment of spatial memory in female, but not male mice
Rex M. Philpot et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Long-lasting impairments in adult neurogenesis, spatial learning and memory from a standard chemotherapy regimen used to treat breast cancer
Catarina Rendeiro et al.
BEHAVIOURAL BRAIN RESEARCH (2016)
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study
Y. T. Cheung et al.
ANNALS OF ONCOLOGY (2015)
Doxorubicin and cyclophosphamide treatment produces anxiety-like behavior and spatial cognition impairment in rats: Possible involvement of hippocampal neurogenesis via brain-derived neurotrophic factor and cyclin D1 regulation
Yoshihisa Kitamura et al.
BEHAVIOURAL BRAIN RESEARCH (2015)
α7 nicotinic acetylcholine receptors control cytochrome c release from isolated mitochondria through kinase-mediated pathways
Galyna Gergalova et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2014)
Antioxidant Activity of Galantamine and Some of its Derivatives
D. Tsvetkova et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Bright lighting conditions during testing increase thigmotaxis and impair water maze performance in BALB/c mice
Yan Huang et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Impaired Cognitive Function and Hippocampal Neurogenesis following Cancer Chemotherapy
Lori-Ann Christie et al.
CLINICAL CANCER RESEARCH (2012)
Neuropsychological Performance in Survivors of Breast Cancer More Than 20 Years After Adjuvant Chemotherapy
Vincent Koppelmans et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Cancer- and Cancer Treatment-Associated Cognitive Change: An Update on the State of the Science
Tim A. Ahles et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research
Michelle C. Janelsins et al.
SUPPORTIVE CARE IN CANCER (2012)
Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model
Gordon Winocur et al.
NEUROPHARMACOLOGY (2011)
Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy
Laura Lyons et al.
PSYCHOPHARMACOLOGY (2011)
Acute and Late Onset Cognitive Dysfunction Associated With Chemotherapy in Women With Breast Cancer
Jeffrey S. Wefel et al.
CANCER (2010)
Cholinesterase Inhibitors as Adjunctive Therapy in Patients with Schizophrenia and Schizoaffective Disorder A Review and Meta-Analysis of the Literature
Salma R. I. Ribeiz et al.
CNS DRUGS (2010)
Cognitive Improvement by Activation of alpha(7) Nicotinic Acetylcholine Receptors: From Animal Models to Human Pathophysiology
Morten S. Thomsen et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Is a picture worth a thousand (forgotten) words?: neuroimaging evidence for the cognitive deficits in 'chemo-fog'/'chemo-brain'
R. B. Raffa
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Cyclophosphamide impairs hippocampus-dependent learning and memory in adult mice: Possible involvement of hippocampal neurogenesis in chemotherapy-induced memory deficits
Miyoung Yang et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2010)
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Carol Kilkenny et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2010)
5-fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus
Sarah Mustafa et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Basic and clinical aspects of non-neuronal acetylcholine: Overview of non-neuronal cholinergic systems and their biological significance
Koichiro Kawashima et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2008)
Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats
Gregory W. Konat et al.
METABOLIC BRAIN DISEASE (2008)
Neuropsychological sequelae of non-central nervous system cancer and cancer therapy
Jeffrey S. Wefel et al.
NEUROPSYCHOLOGY REVIEW (2008)
Cancer chemotherapy impairs contextual but not cue-specific fear memory
Jill E. MacLeod et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Self-Reported Cognitive Impairment in Patients With Cancer
Sadhna Kohli et al.
JOURNAL OF ONCOLOGY PRACTICE (2007)
Physiology and immunology of the cholinergic antiinflammatory pathway
Kevin J. Tracey
JOURNAL OF CLINICAL INVESTIGATION (2007)
A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer
V Jenkins et al.
BRITISH JOURNAL OF CANCER (2006)
Different rankings of inbred mouse strains on the Morris maze and a refined 4-arm water escape task
D Wahlsten et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma - Results of a prospective, randomized, longitudinal trial
JS Wefel et al.
CANCER (2004)
Cognitive impairment associated with chemotherapy for cancer: Report of a workshop
IF Tannock et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Cholinesterase inhibitors used in the treatment of Alzheimer's disease the relationship between pharmacological effects and clinical efficacy
DG Wilkinson et al.
DRUGS & AGING (2004)
Contribution of sex differences in the acute stress response to sex differences in water maze performance in the rat
J Beiko et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors
M Samochocki et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Cytokines and cognition - The case for a head-to-toe inflammatory paradigm
CJ Wilson et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2002)
Share Paper
